This inventor holds 4 USPTO granted patents. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2001-2009.
Company Filing History:
Years Active: 2001-2009
Title: Joyce Tombran-Tink: Innovator in Neurotrophic Factors
Introduction
Joyce Tombran-Tink is a distinguished inventor based in Derwood, MD (US). She has made significant contributions to the field of neurotrophic factors, with a focus on retinal health and neuroprotection. Her innovative work has led to the development of several patents that address critical medical challenges.
Latest Patents
Joyce Tombran-Tink holds 4 patents that showcase her expertise in neurotrophic factors. One of her latest patents involves a purified retinal pigmented epithelium derived neurotrophic factor composition. This invention includes a method for purifying the retinal pigmented epithelium neurotrophic factor and a recombinant DNA molecule that encodes this factor. Additionally, it describes a method for treating tumors, ocular diseases, nerve injuries, and conditions resulting from serine protease activity through the administration of PEDF. Another significant patent focuses on the nucleic acids encoding the neurotrophic protein known as pigment epithelium derived factor (PEDF) and its variants, detailing their effects on neuronal differentiation, neuron survival, and glial inhibition.
Career Highlights
Joyce Tombran-Tink works for the United States of America, as represented by the Secretary, Department of Health and Human Services. Her career is marked by her dedication to advancing medical science through her research and inventions.
Collaborations
Joyce has collaborated with notable colleagues in her field, including Gerald J Chader and Ignacio R Rodriguez. Their combined efforts have contributed to the advancement of knowledge in neurotrophic factors and their applications.
Conclusion
Joyce Tombran-Tink is a pioneering inventor whose work in neurotrophic factors has the potential to transform treatments for various ocular and neurological conditions. Her patents reflect her commitment to improving health outcomes through innovative research.